About Injectable Drugs
Injectable drugs are directly infused into the body with the help of a syringe and a hollow needle. Various modes of infusion are used for the drug delivery. Among them, subcutaneous (SC), intramuscular (IM), and intravenous (IV) are the three major modes. The market encompasses drugs that are used for the prevention and cure of various diseases, and are mainly of two types, namely, biologics and small molecule drugs.
Technavio’s analysts forecast the global injectable drugs market to grow at a CAGR of 8.21% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global injectable drugs market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Injectable Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Sanofi
Other prominent vendors
• Bayer
• Bristol-Myers Squibb
• Merck
• Takeda Pharmaceutical
• Teva Pharmaceutical
Market driver
• Escalation in demand for self-injection devices
• For a full, detailed list, view our report
Market challenge
• High cost of production
• For a full, detailed list, view our report
Market trend
• Increase in industry-academia collaboration
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
• ROA
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Pipeline landscape
PART 07: Market segmentation by molecule type
• Biologics
• Small molecules
PART 08: Geographical segmentation
• Injectable drugs market in Americas
• Injectable drugs market in EMEA
• Injectable drugs market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Rising awareness leading to high demand for injectable drugs
• Increase in industry-academia collaboration
• Expected entry of novel vaccines
• Advent of biosimilars
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• AbbVie
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Sanofi
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Market scenario: Global injectable drugs market 2016
Exhibit 02: Decisive factors for the choice of ROA
Exhibit 03: Major ROA for drugs intake
Exhibit 04: Types of injections
Exhibit 05: Adverse effects of injectable drugs
Exhibit 06: Global injectable drugs market snapshot
Exhibit 07: Global injectable drugs market 2016-2021 ($ billions)
Exhibit 08: Opportunity analysis in global injectable drugs market
Exhibit 09: Five forces analysis
Exhibit 10: Pipeline molecules by key vendors (Phase III)
Exhibit 11: Key clinical trials of key vendors (Phase III)
Exhibit 12: Global injectable drugs market segmentation by molecule type
Exhibit 13: Global injectable drugs market segmentation by molecule type 2016 and 2021 (%)
Exhibit 14: Global biologics injectable drugs market 2016-2021 ($ billions)
Exhibit 15: Top biologic drugs in the injectable drugs market
Exhibit 16: Global small molecules injectable drugs market 2016-2021 ($ billions)
Exhibit 17: Segmentation of global injectable drugs market based on geography 2016 and 2021 (%)
Exhibit 18: Global injectable drugs market by geography 2016-2021 ($ billions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Injectable drugs market in Americas 2016-2021 ($ billions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Injectable drugs market in EMEA 2016-2021 ($ billions)
Exhibit 23: Market scenario in APAC
Exhibit 24: Injectable drugs market in APAC 2016-2021 ($ billions)
Exhibit 25: Major indications finding huge applications of injectable drugs
Exhibit 26: Major reasons to use injectable drugs
Exhibit 27: New cases of diabetes by 2040
Exhibit 28: Major complications involved with the injections
Exhibit 29: Major causes of drug shortage
Exhibit 30: Competitive structure analysis of global injectable drugs market
Exhibit 31: AbbVie: Key highlights
Exhibit 32: AbbVie: Strength assessment
Exhibit 33: AbbVie: Strategy assessment
Exhibit 34: AbbVie: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Key highlights
Exhibit 36: F. Hoffmann-La Roche: Strength assessment
Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 39: GlaxoSmithKline: Key highlights
Exhibit 40: GlaxoSmithKline: Strength assessment
Exhibit 41: GlaxoSmithKline: Strategy assessment
Exhibit 42: GlaxoSmithKline: Opportunity assessment
Exhibit 43: Sanofi: Key highlights
Exhibit 44: Sanofi: Strength assessment
Exhibit 45: Sanofi: Strategy assessment
Exhibit 46: Sanofi: Opportunity assessment
